Insufficient scRNA-seq data for expression of ALOX12B at single-cell level.
Insufficient scRNA-seq data for expression of ALOX12B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 54% | 68.07 | 132 / 245 | 50% | 1.49 | 249 / 502 |
esophagus | 33% | 162.40 | 474 / 1445 | 67% | 10.26 | 123 / 183 |
skin | 72% | 5303.01 | 1300 / 1809 | 13% | 2.38 | 60 / 472 |
tonsil | 0% | 0 | 0 / 0 | 84% | 10.99 | 38 / 45 |
brain | 63% | 50.44 | 1656 / 2642 | 18% | 0.43 | 128 / 705 |
uterus | 1% | 20.02 | 2 / 170 | 42% | 4.64 | 192 / 459 |
intestine | 17% | 9.65 | 165 / 966 | 20% | 0.79 | 108 / 527 |
lung | 2% | 1.97 | 13 / 578 | 29% | 1.41 | 339 / 1155 |
kidney | 3% | 1.38 | 3 / 89 | 25% | 0.44 | 221 / 901 |
stomach | 11% | 12.01 | 41 / 359 | 16% | 0.52 | 47 / 286 |
bladder | 0% | 0 | 0 / 21 | 19% | 0.94 | 96 / 504 |
ovary | 0% | 0 | 0 / 180 | 15% | 0.38 | 65 / 430 |
pancreas | 1% | 1.32 | 3 / 328 | 14% | 0.34 | 25 / 178 |
adrenal gland | 0% | 0 | 0 / 258 | 14% | 0.45 | 32 / 230 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.17 | 4 / 29 |
breast | 1% | 0.32 | 3 / 459 | 6% | 0.14 | 70 / 1118 |
thymus | 0% | 0.28 | 2 / 653 | 6% | 0.53 | 36 / 605 |
liver | 1% | 0.98 | 2 / 226 | 1% | 0.02 | 6 / 406 |
peripheral blood | 2% | 1.01 | 20 / 929 | 0% | 0 | 0 / 0 |
spleen | 1% | 0.59 | 3 / 241 | 0% | 0 | 0 / 0 |
adipose | 1% | 4.29 | 10 / 1204 | 0% | 0 | 0 / 0 |
muscle | 1% | 2.02 | 5 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.40 | 5 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043651 | Biological process | linoleic acid metabolic process |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0034440 | Biological process | lipid oxidation |
GO_0006497 | Biological process | protein lipidation |
GO_0019372 | Biological process | lipoxygenase pathway |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0006665 | Biological process | sphingolipid metabolic process |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0051122 | Biological process | hepoxilin biosynthetic process |
GO_0070257 | Biological process | positive regulation of mucus secretion |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0106237 | Molecular function | arachidonate 12(R)-lipoxygenase activity |
GO_1990136 | Molecular function | linoleate 9S-lipoxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0047677 | Molecular function | arachidonate 8(R)-lipoxygenase activity |
GO_0004052 | Molecular function | arachidonate 12(S)-lipoxygenase activity |
GO_0016853 | Molecular function | isomerase activity |
GO_0016829 | Molecular function | lyase activity |
GO_0016702 | Molecular function | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
Gene name | ALOX12B |
Protein name | Arachidonate 12-lipoxygenase, 12R-type (12R-LOX) (12R-lipoxygenase) (EC 1.13.11.-) (Epidermis-type lipoxygenase 12) Arachidonate 12-lipoxygenase, 12R type |
Synonyms | |
Description | FUNCTION: Catalyzes the regio and stereo-specific incorporation of a single molecule of dioxygen into free and esterified polyunsaturated fatty acids generating lipid hydroperoxides that can be further reduced to the corresponding hydroxy species . In the skin, acts upstream of ALOXE3 on the lineolate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins . Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss . May also play a role in the regulation of the expression of airway mucins . . |
Accessions | ENST00000649809.1 A0A3B3IRK2 O75342 ENST00000647874.1 |